RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos A. Sariol to Macaca mulatta

This is a "connection" page, showing publications Carlos A. Sariol has written about Macaca mulatta.
Connection Strength

3.352
  1. Kanthaswamy S, Oldt RF, Ng J, Smith DG, Mart?nez MI, Sariol CA. Determination of major histocompatibility class I and class II genetic composition of the Caribbean Primate Center specific pathogen-free rhesus macaque (Macaca mulatta) colony based on massively parallel sequencing. J Med Primatol. 2018 12; 47(6):379-387.
    View in: PubMed
    Score: 0.642
  2. Kanthaswamy S, Oldt RF, Ng J, Ruiz-Lambides AV, Maldonado E, Mart?nez MI, Sariol CA. Population Genetic Structure of the Cayo Santiago Colony of Rhesus Macaques (Macaca mulatta). J Am Assoc Lab Anim Sci. 2017 Jul 01; 56(4):396-401.
    View in: PubMed
    Score: 0.598
  3. Kanthaswamy S, Ng J, Hern?ndez-Pacheco R, Ruiz-Lambides A, Maldonado E, Mart?nez MI, Sariol CA. The Population Genetic Composition of Conventional and SPF Colonies of Rhesus Macaques (Macaca mulatta) at the Caribbean Primate Research Center. J Am Assoc Lab Anim Sci. 2016 Mar; 55(2):147-51.
    View in: PubMed
    Score: 0.546
  4. Sariol CA, Gonz?lez-Mart?nez J, Arana T, Gascot S, Su?rez E, Maldonado E, Gerald MS, Rodr?guez M, Kraiselburd EN. Differential distribution of antibodies to different viruses in young animals in the free-ranging rhesus macaques of Cayo Santiago. J Med Primatol. 2006 Dec; 35(6):369-75.
    View in: PubMed
    Score: 0.287
  5. Sariol CA, Arana T, Maldonado E, Gerald M, Gonzalez-Martinez J, Rodriguez M, Kraiselburd EN. Herpes B-virus seroreactivity in a colony of Macaca mulatta: data from the Sabana Seca Field Station, a new specific pathogen-free program. J Med Primatol. 2005 Feb; 34(1):13-9.
    View in: PubMed
    Score: 0.253
  6. Serrano-Collazo C, P?rez-Guzm?n EX, Pantoja P, Hassert MA, Rodr?guez IV, Giavedoni L, Hodara V, Parodi L, Cruz L, Arana T, Mart?nez MI, White L, Brien JD, de Silva A, Pinto AK, Sariol CA. Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies. PLoS Negl Trop Dis. 2020 05; 14(5):e0008285.
    View in: PubMed
    Score: 0.183
  7. P?rez-Guzm?n EX, Pantoja P, Serrano-Collazo C, Hassert MA, Ortiz-Rosa A, Rodr?guez IV, Giavedoni L, Hodara V, Parodi L, Cruz L, Arana T, White LJ, Mart?nez MI, Weiskopf D, Brien JD, de Silva A, Pinto AK, Sariol CA. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses. Nat Commun. 2019 09 20; 10(1):4316.
    View in: PubMed
    Score: 0.174
  8. Pantoja P, P?rez-Guzm?n EX, Rodr?guez IV, White LJ, Gonz?lez O, Serrano C, Giavedoni L, Hodara V, Cruz L, Arana T, Mart?nez MI, Hassert MA, Brien JD, Pinto AK, de Silva A, Sariol CA. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun. 2017 06 23; 8:15674.
    View in: PubMed
    Score: 0.149
  9. Sariol CA, Mart?nez MI, Rivera F, Rodr?guez IV, Pantoja P, Abel K, Arana T, Giavedoni L, Hodara V, White LJ, Angler? YI, Montaner LJ, Kraiselburd EN. Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One. 2011 Apr 29; 6(4):e19323.
    View in: PubMed
    Score: 0.098
  10. Sariol CA, Mu?oz-Jord?n JL, Abel K, Rosado LC, Pantoja P, Giavedoni L, Rodriguez IV, White LJ, Mart?nez M, Arana T, Kraiselburd EN. Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol. 2007 Jun; 14(6):756-66.
    View in: PubMed
    Score: 0.074
  11. Rosado MRS, Marzan-Rivera N, Watowich MM, Valle ADN, Pantoja P, Pavez-Fox MA, Siracusa ER, Cooper EB, Valle JEN, Phillips D, Ruiz-Lambides A, Martinez MI, Montague MJ, Platt ML, Higham JP, Brent LJN, Sariol CA, Snyder-Mackler N. Immune cell composition varies by age, sex and exposure to social adversity in free-ranging Rhesus Macaques. Geroscience. 2024 Apr; 46(2):2107-2122.
    View in: PubMed
    Score: 0.058
  12. Chen RE, Smith BK, Errico JM, Gordon DN, Winkler ES, VanBlargan LA, Desai C, Handley SA, Dowd KA, Amaro-Carambot E, Cardosa MJ, Sariol CA, Kallas EG, S?kaly RP, Vasilakis N, Fremont DH, Whitehead SS, Pierson TC, Diamond MS. Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host Microbe. 2021 11 10; 29(11):1634-1648.e5.
    View in: PubMed
    Score: 0.050
  13. Stauft CB, Song Y, Gorbatsevych O, Pantoja P, Rodriguez IV, Futcher B, Sariol CA, Wimmer E. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2. Virology. 2019 11; 537:237-245.
    View in: PubMed
    Score: 0.043
  14. Abdulhaqq SA, Martinez M, Kang G, Rodriguez IV, Nichols SM, Beaumont D, Joseph J, Azzoni L, Yin X, Wise M, Weiner D, Liu Q, Foulkes A, M?nch J, Kirchhoff F, Coutifaris C, Tomaras GD, Sariol C, Marx PA, Li Q, Kraiselburd EN, Montaner LJ. Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaques. Nat Commun. 2019 08 21; 10(1):3753.
    View in: PubMed
    Score: 0.043
  15. Abdulhaqq SA, Martinez MI, Kang G, Foulkes AS, Rodriguez IV, Nichols SM, Hunter M, Sariol CA, Ruiz LA, Ross BN, Yin X, Speicher DW, Haase AT, Marx PA, Li Q, Kraiselburd EN, Montaner LJ. Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):405-13.
    View in: PubMed
    Score: 0.030
  16. Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A. 2014 Feb 04; 111(5):1939-44.
    View in: PubMed
    Score: 0.029
  17. Rivera-Amill V, Kumar R, Noel RJ, Garcia Y, Rodriguez IV, Martinez M, Sariol CA, Kraiselburd E, Iszard M, Mukherji M, Kumar S, Giavedoni LD, Kumar A. Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines. AIDS Res Hum Retroviruses. 2010 Aug; 26(8):919-22.
    View in: PubMed
    Score: 0.023
  18. Aidoo M, Otten RA, Rodriguez V, Sariol CA, Martinez M, Kraiselburd E, Robinson H, Folks T, Butera S, Ellenberger D. Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations. Vaccine. 2007 Aug 29; 25(35):6474-81.
    View in: PubMed
    Score: 0.019
  19. Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, Nichol ST, Lipkin WI. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006 Dec; 20(14):2519-30.
    View in: PubMed
    Score: 0.018
  20. Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology. 2006 Aug 15; 352(1):216-25.
    View in: PubMed
    Score: 0.017
  21. Ellenberger D, Wyatt L, Li B, Buge S, Lanier N, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Vogt J, Smith J, Otten R, Montefiori D, Kraiselburd E, Moss B, Robinson H, McNicholl J, Butera S. Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs. Virology. 2005 Sep 15; 340(1):21-32.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support